相关实验视频

Updated: Jan 13, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

评估长效注射性艾滋病毒治疗:卡博特格拉维尔和里尔皮维林的最新情况

Gabriele Loi¹, Antonella Castagna^1,2, Camilla Muccini²

¹Vita-Salute San Raffaele University, Milan, Italy.

Expert review of anti-infective therapy

|January 8, 2026

概括

使用卡博特格拉维尔 (CAB) 和里尔皮维林 (RPV) 的长期注射抗逆转录病毒疗法为每日口服的艾滋病毒药物提供了有效的替代品. 这种注射方案提供了持久的病毒抑制,具有良好的安全性,改善生活质量.

科学领域:

长效注射抗逆转录病毒疗法的药理学和临床应用.

背景情况:

每日口服抗逆转录病毒疗法 (ART) 对艾滋病毒,虽然有效,但提出了影响生活质量的坚持挑战.
长效注射性卡博特格拉维尔 (CAB) 和里尔皮维林 (RPV) 提供了一种新的注射途径,减少了每天口服剂量的需要.

研究的目的:

审查药理性质和临床证据,支持CAB和RPV的长效注射方案.
评估这种新的艾滋病毒治疗方式的疗效,安全性和实施考虑因素.

主要方法:

来自第二期 (LATTE,LATTE-2) 和第三期 (FLAIR,ATLAS,ATLAS-2M,SOLAR) 临床试验的数据摘要.
对支持持续药物水平的药理动力学和药理动力学研究的审查.
对安全数据的分析,包括注射部位反应等不良事件.

主要成果:

长期作用的CAB+RPV在维持病毒抑制方面表现为每日口服治疗的非劣势.
在评估可注射方案的研究中观察到持久的病毒学控制.
安全性概况是有利的,注射部位反应是最常见的,通常是轻微和短暂的不良事件.

结论:

长期作用的CAB+RPV代表了艾滋病毒管理的重大进步,为那些宁愿避免每天服用口服药物的患者提供了可行的选择.
成功实施需要仔细选择患者,可靠的注射注射系统和解决药理学考虑的策略.
未来的研究应该集中在扩大资格,开发超长效的配方,并确保在差异化艾滋病毒护理模式内提供公平的机会.

关键词:

艾滋病病毒艾滋病病毒艾滋病病毒坚持性坚持性抗逆转录病毒药物治疗卡博特格拉维尔 (Cabotegravir) 是一个长效药物是一种长效药物.里尔皮维林 (Rilpivirine) 是一种污名污名污名污名

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Retroviruses

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...

Subviral Agents

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...